Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy

Pediatric Infectious Disease Journal

Volumn 31, Issue 2, 2012, Pages 193-195

  Cruz, Andrea T ^a   Starke, Jeffrey R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adherence; Children; Health department; Tuberculosis infection

Indexed keywords

ISONIAZID; LEVOFLOXACIN; LEVOFLOXACIN PLUS PYRAZINAMIDE; PYRAZINAMIDE; RIFAMPICIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONFIDENCE INTERVAL; HUMAN; INFANT; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; NEWBORN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LATENT TUBERCULOSIS; MALE; MEDICATION ADHERENCE;

EID: 84858150692     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318236984f     Document Type: Article

References (10)

1. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:691.
2. Horsburgh CR Jr, Goldberg S, Bethel J, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010; 137:401-409.
3. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161:S221-S247.
4. Cass AD, Talavera GA, Gresham LS, et al. Structured behavioral intervention to increase children's adherence to treatment for latent tuberculosis infection. Int J Tuberc Lung Dis. 2005;9:415-420. (Pubitemid 40524033)
5. Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59:1-25.
6. Glaziou P, Floyd K, Korenromp EL, et al. Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality. Bull World Health Organ. 2011;89:573-582.
7. Munsiff SS, Joseph S, Ebrahimzadeh A, et al. Rifampin-monoresistant tuberculosis in New York City, 1993-1994. Clin Infect Dis. 1997;25:1465-1467. (Pubitemid 28022689)
8. Manders AJ, Banerjee A, van de Borne HW, et al. Can guardians supervise TB therapy as well as health workers? A study on adherence during the intensive phase. Int J Tuberc Lung Dis. 2001;5:838-842. (Pubitemid 32843677)
9. Le Roux SM, Cotton MF, Golub JE, et al. Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing 2 dosing schedules. BMC Med. 2009;7:67.
10. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(suppl 1):S79-S87. (Pubitemid 44885645)